Search for: "Teva Pharmaceuticals" Results 381 - 400 of 1,423
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jun 2018, 9:15 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229 (Supreme Court 2018), the petitioner has asked the Supreme Court to offer its statement on whether Congress altered the “on sale bar” to now apply only to non-confidential sales or offers. [read post]
14 Jun 2018, 3:45 am by Steve Brachmann
Regis and Allergan, appellees Mylan and Teva as well as the respondent for the U.S. federal government, without giving much clue as to whether the panel favored the argument offered by any particular side. [read post]
7 Jun 2018, 4:59 pm by Patent Docs
.; Teva Pharmaceuticals International GMGH; and Teva Pharmaceuticals USA, Inc. [read post]
31 May 2018, 3:02 pm by Lawrence B. Ebert
The FDA approved generic Truvada in 2017, with Teva and Gilead making a deal. [read post]
26 Apr 2018, 4:48 am by Laura Reynolds
This case concerned an SPC Gilead had obtained for the combination of tenofovir and emtricitabine based upon Gilead’s patent, which claimed “A pharmaceutical composition comprising a compound according to any one of claims 1 to 25 together with a pharmaceutically acceptable carrier and optionally other therapeutic ingredients”. [read post]
11 Apr 2018, 7:17 pm by Aurora Barnes
Teva Pharmaceuticals USA Inc. 17-1229 Issue: Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]
9 Apr 2018, 7:35 am by Dennis Crouch
 17-1229 Brief for Amicus Brief amicus curiae of Pharmaceutical Research and Manufacturers of America. [read post]
21 Mar 2018, 1:34 pm by Pierre T. Nguyen
Une de ces unicités a récemment refait surface dans la décision du Federal Circuit dans Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc.: la mise en vente pouvant faire anticiper un dépôt de brevet américain. [read post]
16 Mar 2018, 7:47 am by Law Office of Dayna L. Jones
The suit is targeting big pharma companies such as Purdue Pharma, Teva Pharmaceuticals, Cephalon and Johnson & Johnson. [read post]
16 Mar 2018, 7:47 am by Law Office of Dayna L. Jones
The suit is targeting big pharma companies such as Purdue Pharma, Teva Pharmaceuticals, Cephalon and Johnson & Johnson. [read post]
7 Mar 2018, 5:59 am by Robert Kraft
” The lawsuit details how Purdue Pharma, Johnson & Johnson, Teva Pharmaceutical Industries, Endo Pharmaceuticals and others allegedly “pushed highly addictive, dangerous opioids, falsely representing to doctors that patients would only rarely succumb to drug addiction. [read post]
5 Mar 2018, 4:25 pm by Law Offices of Jeffrey S. Glassman
Defendants in those cases include Johnson & Johnson, Janssen Pharmaceuticals, Teva Pharmaceuticals and Purdue Pharma, as well as several wholesale medication distributors. [read post]
5 Mar 2018, 4:25 pm by Law Offices of Jeffrey S. Glassman
Defendants in those cases include Johnson & Johnson, Janssen Pharmaceuticals, Teva Pharmaceuticals and Purdue Pharma, as well as several wholesale medication distributors. [read post]
25 Feb 2018, 11:45 am
   Because the claims of the patents are directed to pharmaceutical compositions and methods used to treat human medical conditions, it was not shown that there could be any other commercially relevant ways to practice the invention without FDA approval. [read post]
16 Feb 2018, 2:06 pm by Dean I. Weitzman, Esq.
Also named in the lawsuit were Allergan, Cephalon, Teva Pharmaceuticals, Endo Health Solutions and Endo Pharmaceuticals, Janssen Pharmaceuticals, Johnson & Johnson and Purdue Frederick Co. [read post]
2 Feb 2018, 1:31 pm by Gregory Sephton
Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., Case 2016-1284, 2016-1787 (Fed. [read post]